Evidence map›Paper›PMID 34589963›Full record

ArticleJTO clinical and research reports2020

Src-Homology 2 Domain-Containing Phosphatase 2 in Resected

Masaoki Ito, Jordi Codony-Servat, Ana Giménez-Capitán, Mireia Serra-Mitjans, Francisco Pérez-Ochoa, David Llige, Imane Chaib, Ramón Rami-Porta, Carme Obiols, Sergi Call and 7 more

Open access · goldAbstract read
In one paragraph

Article in JTO clinical and research reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Insights intoCancers · 2023
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 2 countries.

Masaoki ItoPangaea Oncology, Laboratory of Molecular Biology, Quirón-Dexeus University Institute, Barcelona, Spain.
Jordi Codony-ServatPangaea Oncology, Laboratory of Molecular Biology, Quirón-Dexeus University Institute, Barcelona, Spain.
Ana Giménez-CapitánPangaea Oncology, Laboratory of Molecular Biology, Quirón-Dexeus University Institute, Barcelona, Spain.
Mireia Serra-MitjansThoracic Surgery Service, University Hospital Mutua de Terrassa, Terrassa, Spain.
Francisco Pérez-OchoaDepartment of Pathology, University Hospital Mutua de Terrassa, Terrassa, Spain.
David LligeLaboratory of Cellular and Molecular Biology, Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain.
Imane ChaibLaboratory of Cellular and Molecular Biology, Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain.
Ramón Rami-PortaThoracic Surgery Service, University Hospital Mutua de Terrassa, Terrassa, Spain.
Carme ObiolsThoracic Surgery Service, University Hospital Mutua de Terrassa, Terrassa, Spain.
Sergi CallThoracic Surgery Service, University Hospital Mutua de Terrassa, Terrassa, Spain.
Manuela IglesiasThoracic Surgery Service, University Hospital Mutua de Terrassa, Terrassa, Spain.
José Belda-SanchisThoracic Surgery Service, University Hospital Mutua de Terrassa, Terrassa, Spain.
Xavier Tarroch-SarasaDepartment of Pathology, University Hospital Mutua de Terrassa, Terrassa, Spain.
Niki KarachaliouPangaea Oncology, Laboratory of Molecular Biology, Quirón-Dexeus University Institute, Barcelona, Spain.
Miguel Angel Molina-VilaPangaea Oncology, Laboratory of Molecular Biology, Quirón-Dexeus University Institute, Barcelona, Spain.
Morihito OkadaDepartment of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Rafael RosellLaboratory of Cellular and Molecular Biology, Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain.
University Hospital Mútua de Terrassa · ESInstitut d'Investigació en Ciències de la Salut Germans Trias i Pujol · ESUSP Institut Universitari Dexeus · ESCentre for Biomedical Network Research on Rare Diseases · ESHiroshima University · JPUniversitat Autònoma de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction

methodsWe examined resected LUAD cases from Japan and Spain. mRNA expression levels of

resultsA total of 50 of 100

conclusionsElevated

Indexed as

EGFRLung adenocarcinomaRecurrenceSHP2Surgery

Identifiers

PMID34589963
PMCPMC8474259
OpenAlexW3081434137

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.